BSE Live
Jan 20, 14:41Prev. Close
1548.35
Open Price
1545.10
Bid Price (Qty.)
1547.90 (38)
Offer Price (Qty.)
1550.95 (6)
NSE Live
Jan 20, 14:41Prev. Close
1549.50
Open Price
1549.80
Bid Price (Qty.)
1548.70 (7)
Offer Price (Qty.)
1550.00 (2)
| Balance Sheet of Emcure Pharmaceuticals (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | |
| 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | |||||
| SHAREHOLDER'S FUNDS | |||||
| Equity Share Capital | 45.21 | 45.21 | 35.17 | 35.17 | |
| Total Share Capital | 45.21 | 45.21 | 35.17 | 35.17 | |
| Reserves and Surplus | 813.51 | 687.03 | 565.34 | 482.04 | |
| Total Reserves and Surplus | 813.51 | 687.03 | 565.34 | 482.04 | |
| Total Shareholders Funds | 858.72 | 732.24 | 600.51 | 517.20 | |
| NON-CURRENT LIABILITIES | |||||
| Long Term Borrowings | 253.01 | 326.30 | 307.49 | 190.93 | |
| Deferred Tax Liabilities [Net] | 77.78 | 97.33 | 70.49 | 57.27 | |
| Other Long Term Liabilities | 41.08 | 38.06 | 54.98 | 38.63 | |
| Long Term Provisions | 8.33 | 6.54 | 6.22 | 48.05 | |
| Total Non-Current Liabilities | 380.21 | 468.23 | 439.18 | 334.88 | |
| CURRENT LIABILITIES | |||||
| Short Term Borrowings | 289.17 | 236.86 | 164.85 | 126.18 | |
| Trade Payables | 297.48 | 324.97 | 236.61 | 213.42 | |
| Other Current Liabilities | 222.33 | 309.91 | 248.91 | 191.26 | |
| Short Term Provisions | 47.95 | 69.31 | 27.85 | 30.09 | |
| Total Current Liabilities | 856.92 | 941.05 | 678.21 | 560.94 | |
| Total Capital And Liabilities | 2,095.85 | 2,141.52 | 1,717.90 | 1,413.02 | |
| ASSETS | |||||
| NON-CURRENT ASSETS | |||||
| Tangible Assets | 667.65 | 642.76 | 576.86 | 581.39 | |
| Intangible Assets | 56.77 | 87.01 | 73.11 | 13.62 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 798.27 | 909.44 | 769.36 | 674.53 | |
| Non-Current Investments | 228.15 | 183.43 | 170.20 | 109.15 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 197.30 | 143.91 | 81.45 | 63.30 | |
| Other Non-Current Assets | 5.35 | 2.85 | 3.61 | 2.20 | |
| Total Non-Current Assets | 1,229.07 | 1,239.63 | 1,024.62 | 849.19 | |
| CURRENT ASSETS | |||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 342.82 | 334.82 | 231.70 | 177.68 | |
| Trade Receivables | 401.33 | 344.60 | 310.44 | 212.12 | |
| Cash And Cash Equivalents | 33.70 | 69.78 | 9.92 | 20.30 | |
| Short Term Loans And Advances | 75.68 | 113.11 | 106.80 | 127.86 | |
| OtherCurrentAssets | 13.25 | 39.59 | 34.43 | 25.87 | |
| Total Current Assets | 866.79 | 901.90 | 693.29 | 563.84 | |
| Total Assets | 2,095.85 | 2,141.52 | 1,717.90 | 1,413.02 | |
| OTHER ADDITIONAL INFORMATION | |||||
| CONTINGENT LIABILITIES, COMMITMENTS | |||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | |||||
| Raw Materials | 0.00 | 209.66 | 199.79 | 276.77 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 12.22 | 70.36 | 20.43 | |
| EXPENDITURE IN FOREIGN EXCHANGE | |||||
| Expenditure In Foreign Currency | 5.25 | 42.72 | 39.55 | 21.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | |||||
| Dividend Remittance In Foreign Currency | -- | 0.29 | 0.40 | 0.30 | |
| EARNINGS IN FOREIGN EXCHANGE | |||||
| FOB Value Of Goods | 119.55 | 849.45 | 653.13 | 702.88 | |
| Other Earnings | -- | -- | -- | -- | |
| BONUS DETAILS | |||||
| Bonus Equity Share Capital | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | |||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 228.15 | 183.43 | 170.20 | 109.15 | |
| CURRENT INVESTMENTS | |||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- |
09.01.2026
07.01.2026
24.12.2025
10.12.2025
17.11.2025
Emcure Pharmace Consolidated September 2025 Net Sales at Rs 2,269.82 crore, up 13.38% Y-o-Y
12.11.2025
Emcure Pharmace Standalone September 2025 Net Sales at Rs 1,260.60 crore, up 14.12% Y-o-Y
07.08.2025
Emcure Pharmace Standalone June 2025 Net Sales at Rs 1,096.57 crore, up 13.01% Y-o-Y
27.05.2025
Emcure Pharmace Consolidated March 2025 Net Sales at Rs 2,116.25 crore, up 19.47% Y-o-Y